PMD Device Solutions

The decision to focus on these high-growth regions underscores the company’s commitment to meeting the rising demand for its preventive healthcare solutions, which include integrated care solutions through continuous respiratory rate monitoring and remote patient monitoring programmes. By concentrating its efforts in these markets, PMDS aims to deepen customer engagement and further solidify its global presence.

Myles Murray, CEO of PMD Device Solutions, commented: “This realignment reflects our unwavering commitment to spreading the adoption of our innovative products and services on a global scale. By proactively supporting our growth targets and diversifying our revenue streams, we are positioning the company for long-term success. Our team has done an incredible job, and this restructuring builds upon their successes, allowing us to continue driving forward with confidence."

The restructuring will involve consolidating up to 60% of European roles across compliance, engineering, and clinical care specialists. This shift will focus resources to better support sales activities and new contract efforts in the UK and US markets, while also strengthening the market access programme in the German market. This realignment enables PMDS to optimise its operations for growth in these strategic regions.

In addition to accelerating global sales, the restructuring is designed to improve operational efficiency and contribute positively to the company’s financial health, further supporting PMDS’s long-term sustainability and profitability.
PMDS is confident that these actions will not only solidify its market leadership but also improve its ability to deliver cutting-edge healthcare solutions to medical professionals worldwide.